Latest article: |
New Diagnostic Test Helping in the Fight Against Ovarian Cancer
20 Aug 2010: A new test for ovarian cancer was demonstrated to be 99% to 100% accurate over 100 patient samples by Researchers at Georgia Institute of Technology. This new diagnostic technique is able to test a single drop of blood serum using JEOL's AccuTOF™-DART® mass spectrometer.
JEOL USA
|
|
|
Recent articles: |
|
New Kits for Patients with Multiple Myeloma
 19 Aug 2010: Binding Site has launched 4 more Hevylite™ kits. Hevylite is CE marked for use in monitoring patients with Multiple Myeloma and other B cell dyscrasias.
The Binding Site Ltd
|
Randox Provides Improved Stroke and Heart Attack Patient Profiling
 11 Aug 2010: Randox now offers Metabolic Syndrome Arrays for the simultaneous determination of analytes associated with Metabolic Syndrome and related disorders for improved patient profiling. Individuals with Metabolic Syndrome are more likely to have a stroke, heart attack or develop type 2 diabetes.
Randox Laboratories Ltd
|
BioDot to Showcase Equipment for Research and Manufacture of Diagnostic Kits at AACC 2010
 19 Jul 2010: BioDot will be highlighting its core "batch" and "in line" systems for development and manufacturing of lateral flow tests. These systems will include quantitative dispensing, laminating, cutting and assembly. In addition, BioDot will be showcasing products for Biochip and Biosensor development and manufacturing around its proprietary dispensing technology.
BioDot Inc.
|
New Assays to Offer More Comprehensive Menu for Androgen and Prostate Testing
 15 Jul 2010: A new fully automated Sex Hormone Binding Globulin (SHBG) immunoassay for testing plasma or serum samples on the ADVIA Centaur® platform has been developed by Siemens Healthcare Diagnostics.
Siemens Medical Solutions Diagnostics
|
Pittcon 2011 Announces its Annual Call for Topics Conferee Networking Sessions
15 Jul 2010: Topics must be received electronically by July 16, 2010. The Pittcon Conferee Networking Committee will review the submitted topics and selections will be completed by late August. Final session topics will be posted to the Pittcon website in October.
The Pittsburgh Conference
|
New Kits Provide Earlier Detection of Heart Damage
 13 Jul 2010: Alere International launches three improved tests for earlier detection of low levels of TnI which improves outcomes and benefits the patient. The kits are: Troponin I - a single-analyte, improved sensitivity Troponin I (TnI) test, Cardio2 - a two analyte panel consisting of the new Troponin I and BNP as well as Cardio3 - a three analyte panel consisting of the new Troponin I, BNP and CK-MB.
Alere International
|
Pittcon to Participate in International Year of Chemistry (IYC)
22 Jun 2010: Extra activities to celebrate the International Year of Chemistry (IYC) at Pittcon 2011 have been announced. The extra programs include Science Week, which will serve the city of Atlanta and surrounding immunology, and on a more global level, and the Technical Program, which will include sessions on how chemical research is critical for solving global problems involving food, water, health, energy and transportation.
The Pittsburgh Conference
|
Leica Microsystems to Develop an Automated HER2 FISH Test with the Leica BOND Staining Platform
 22 Jun 2010: Leica Microsystems GmbH and Abbott have reached an agreement for Abbott to supply fluorescence in situ hybridization (FISH) probes that target the HER2 gene locus. The probes will be used to develop a fully automated FISH solution for HER2 testing on the Leica Microsystems’ BOND™ an automated advanced staining platform.
Leica Microsystems GmbH
|
Human Oncostatin M is Functionally Equivalent to Mouse LIF in Supporting Mouse ES Cell Pluripotency & Germline Competency
21 Jun 2010: In this application note R&D Systems demonstrate human OSM is able to maintain ES cell pluripotency in a similar manner to mouse LIF, including long-term maintenance of pluripotency and the ability to differentiate in vitro, the ability to activate STAT3, and germline transmission competency. The study suggests that OSM may be an additional factor that plays a role in early embryonic development and that it may be used as an alternative to LIF in mouse ES cell culture.
R&D Systems, Inc.
|
blood transfusion
